Emergent BioSolutions Inc.EBSNYSE
Loading
Pre-Tax Margin Over TimeExpanding
Percentile Rank36
5Y CAGR-15.7%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

5Y CAGR
-15.7%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM11.15%+181.4%
2024-13.69%+80.4%
2023-69.68%-255.6%
2022-19.60%-214.6%
202117.10%-34.5%
202026.11%+273.2%
20197.00%-32.8%
201810.42%-50.7%
201721.14%+4.2%
201620.29%-